| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.86B | 4.82B | 4.70B | 4.52B | 4.18B | 3.42B |
| Gross Profit | 2.95B | 1.20B | 3.44B | 3.37B | 3.13B | 2.50B |
| EBITDA | 3.22B | 3.25B | 3.51B | 3.34B | 5.41B | 2.78B |
| Net Income | 1.90B | 1.78B | 2.07B | 2.15B | 4.35B | 1.95B |
Balance Sheet | ||||||
| Total Assets | 19.85B | 20.21B | 19.75B | 19.81B | 17.55B | 17.38B |
| Cash, Cash Equivalents and Short-Term Investments | 134.61M | 318.10M | 447.42M | 370.00M | 775.25M | 734.60M |
| Total Debt | 9.71B | 10.25B | 9.35B | 9.10B | 6.87B | 7.48B |
| Total Liabilities | 10.53B | 10.87B | 9.94B | 9.70B | 7.39B | 7.96B |
| Stockholders Equity | 9.22B | 9.25B | 9.71B | 10.01B | 10.07B | 9.34B |
Cash Flow | ||||||
| Free Cash Flow | 3.06B | 2.90B | 2.71B | 2.79B | 2.66B | 2.27B |
| Operating Cash Flow | 3.18B | 3.19B | 3.13B | 3.25B | 3.12B | 2.54B |
| Investing Cash Flow | -1.55B | -1.69B | -1.00B | -3.54B | 1.12B | -5.56B |
| Financing Cash Flow | -1.78B | -1.63B | -2.08B | -112.93M | -4.19B | 3.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $1.63B | 10.70 | 6.27% | 13.07% | -13.63% | -24.40% | |
74 Outperform | $31.62B | 28.69 | 6.97% | 5.01% | 4.16% | 3.52% | |
73 Outperform | $54.30B | 22.59 | 20.48% | 4.63% | 2.90% | -3.92% | |
69 Neutral | $9.15B | 25.18 | 11.95% | 5.69% | 5.02% | -15.68% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | $5.81B | 25.40 | 9.33% | 8.28% | -1.65% | 27.25% | |
61 Neutral | $61.35M | 44.10 | 4.34% | 5.63% | 1.40% | -4.84% |